Stem Cell Trials Show Early Promise for Mesothelioma Treatment, Baron & Budd … – Business Wire (press release)
|
Stem Cell Trials Show Early Promise for Mesothelioma Treatment, Baron & Budd …
Business Wire (press release) Defactnib is being tested to gauge its effectiveness in killing stem cells, which have been linked to the spreading of tumors as well as their recurrence. While the main focus of the trial has been on treating mesothelioma cells, positive results have … |
